NR2C2
NR2C2 (nuclear receptor subfamily 2 group C member 2) is an orphan nuclear receptor that can act as either a repressor or an activator of transcription. It is also known as TAK1, TR2R1, hTAK1 and TR4. Browse Assay Genie's current range of NR2C2 research reagents below, or read on for the biology behind the target.
NR2C2 is an orphan nuclear receptor that binds hormone response elements (HREs) made up of two direct repeats of the 5'-AGGTCA-3' half site. Depending on context it can repress or activate transcription. It is an important repressor of several nuclear receptor signalling pathways, including those of the retinoic acid receptor, retinoid X receptor, vitamin D3 receptor, thyroid hormone receptor and oestrogen receptor. It also antagonises PPARA-mediated transactivation, and it activates the transcriptional activity of LHCG.
Together with NR2C1, the NR2C2 protein forms the core of the DRED (direct repeat erythroid-definitive) complex, which represses embryonic and foetal globin transcription, including that of GATA1. NR2C2 plays a fundamental role in early embryonic development and in embryonic stem cells. It is required for normal spermatogenesis and cerebellum development, may regulate gene expression during the late phase of spermatogenesis, and appears to be important for neurodevelopmentally regulated behaviour.
The NR2C2 gene belongs to the nuclear hormone receptor family, NR2 subfamily. Members of this family act as ligand-activated transcription factors in development, cellular differentiation and homeostasis. NCBI Gene notes that the encoded protein helps protect cells from oxidative stress and damage induced by ionising radiation. Loss of the equivalent gene in mouse (Nr2c2) results in growth retardation, severe spinal curvature, subfertility, premature ageing and prostatic intraepithelial neoplasia. Alternative splicing produces multiple transcript variants that encode different isoforms.
NR2C2 represses retinoic acid, retinoid X, vitamin D3, thyroid hormone and oestrogen receptor pathways, making it a key node in nuclear receptor crosstalk.
With NR2C1, NR2C2 forms the DRED complex that represses embryonic and foetal globin transcription, relevant to studies of erythroid gene control.
NR2C2 is required for normal spermatogenesis and may regulate gene expression in its late phase; its loss in mouse causes subfertility.
NR2C2 acts in early embryonic development, embryonic stem cells and cerebellum development, and appears important for neurodevelopmentally regulated behaviour.
NR2C2 is an orphan nuclear receptor that binds direct-repeat AGGTCA response elements and can repress or activate transcription. It represses several nuclear receptor pathways, forms the DRED complex with NR2C1 to repress globin genes, and is required for normal spermatogenesis and cerebellum development.
NR2C2 is also called TAK1, TR2R1, hTAK1 and TR4. Its earlier HGNC name was nuclear receptor subfamily 2, group C, member 2. NCBI Gene reports that alternative splicing yields multiple transcript variants encoding different isoforms of the protein.
NR2C2 has mouse and rat orthologs, both named Nr2c2. In mouse, loss of the gene causes growth retardation, severe spinal curvature, subfertility, premature ageing and prostatic intraepithelial neoplasia. Check the datasheet of any product for its validated reactivity.
Other nuclear receptors, orphan receptors and nuclear receptor co-regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P49116; product specifications from Assay Genie datasheets.